154 related articles for article (PubMed ID: 31176573)
21. Comparative expression of thioredoxin-1 in uterine leiomyomas and myometrium.
Hou P; Zhao L; Li Y; Luo F; Wang S; Song J; Bai J
Mol Hum Reprod; 2014 Feb; 20(2):148-54. PubMed ID: 24130091
[TBL] [Abstract][Full Text] [Related]
22. Uterine sarcomas versus leiomyomas: gray-scale and Doppler sonographic findings.
Aviram R; Ochshorn Y; Markovitch O; Fishman A; Cohen I; Altaras MM; Tepper R
J Clin Ultrasound; 2005 Jan; 33(1):10-3. PubMed ID: 15690441
[TBL] [Abstract][Full Text] [Related]
23. T2 hyperintense myometrial tumors: can MRI features differentiate leiomyomas from leiomyosarcomas?
Rio G; Lima M; Gil R; Horta M; Cunha TM
Abdom Radiol (NY); 2019 Oct; 44(10):3388-3397. PubMed ID: 31250178
[TBL] [Abstract][Full Text] [Related]
24. Expression of the O-linked N-acetylglucosamine containing epitope H in normal myometrium and uterine smooth muscle cell tumors.
Sgantzos MN; Galani V; Arvanitis LD; Charchanti A; Psathas P; Nakou M; Havaki S; Kallioras V; Marinos E; Vamvakopoulos NC; Kittas C
Pathol Res Pract; 2007; 203(1):31-7. PubMed ID: 17129677
[TBL] [Abstract][Full Text] [Related]
25. MRI findings in-between leiomyoma and leiomyosarcoma: a Rad-Path correlation of degenerated leiomyomas and variants.
Bura V; Pintican RM; David RE; Addley HC; Smith J; Jimenez-Linan M; Lee J; Freeman S; Georgiu C
Br J Radiol; 2021 Sep; 94(1125):20210283. PubMed ID: 34289327
[TBL] [Abstract][Full Text] [Related]
26. MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors.
Schwetye KE; Pfeifer JD; Duncavage EJ
Hum Pathol; 2014 Jan; 45(1):65-70. PubMed ID: 24196187
[TBL] [Abstract][Full Text] [Related]
27. Assessment of MR Imaging as a Tool to Differentiate between the Major Histological Types of Uterine Sarcomas.
Sumi A; Terasaki H; Sanada S; Uchida M; Tomioka Y; Kamura T; Yano H; Abe T
Magn Reson Med Sci; 2015; 14(4):295-304. PubMed ID: 26104072
[TBL] [Abstract][Full Text] [Related]
28. PI3K/Akt/mTOR signaling & its regulator tumour suppressor genes
Makker A; Goel MM; Mahdi AA; Bhatia V; Das V; Agarwal A; Pandey A
Indian J Med Res; 2016 May; 143(Supplement):S112-S119. PubMed ID: 27748285
[TBL] [Abstract][Full Text] [Related]
29. Expression of the mitogen-inducible gene-2 (mig-2) is elevated in human uterine leiomyomas but not in leiomyosarcomas.
Kato K; Shiozawa T; Mitsushita J; Toda A; Horiuchi A; Nikaido T; Fujii S; Konishi I
Hum Pathol; 2004 Jan; 35(1):55-60. PubMed ID: 14745725
[TBL] [Abstract][Full Text] [Related]
30. Potential mechanisms of aberrant DNA hypomethylation on the x chromosome in uterine leiomyomas.
Sato S; Maekawa R; Yamagata Y; Asada H; Tamura I; Lee L; Okada M; Tamura H; Sugino N
J Reprod Dev; 2014 Mar; 60(1):47-54. PubMed ID: 24291816
[TBL] [Abstract][Full Text] [Related]
31. An immunohistochemical analysis of stathmin 1 expression in uterine smooth muscle tumors: differential expression in leiomyosarcomas and leiomyomas.
Allen MM; Douds JJ; Liang SX; Desouki MM; Parkash V; Fadare O
Int J Clin Exp Pathol; 2015; 8(3):2795-801. PubMed ID: 26045786
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of MED12 mutations in uterine and extrauterine smooth muscle tumours.
Matsubara A; Sekine S; Yoshida M; Yoshida A; Taniguchi H; Kushima R; Tsuda H; Kanai Y
Histopathology; 2013 Mar; 62(4):657-61. PubMed ID: 23347103
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical detection of promyelocytic leukemia zinc finger and histone 1.5 in uterine leiomyosarcoma and leiomyoma.
Momeni M; Kalir T; Farag S; Kinoshita Y; Roman TY; Chuang L; Fishman DA; Burstein DE
Reprod Sci; 2014 Sep; 21(9):1171-6. PubMed ID: 24784718
[TBL] [Abstract][Full Text] [Related]
34. Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors.
Mäkinen N; Kämpjärvi K; Frizzell N; Bützow R; Vahteristo P
Mol Cancer; 2017 Jun; 16(1):101. PubMed ID: 28592321
[TBL] [Abstract][Full Text] [Related]
35. Aberrant DNA methylation status in human uterine leiomyoma.
Yamagata Y; Maekawa R; Asada H; Taketani T; Tamura I; Tamura H; Ogane J; Hattori N; Shiota K; Sugino N
Mol Hum Reprod; 2009 Apr; 15(4):259-67. PubMed ID: 19218588
[TBL] [Abstract][Full Text] [Related]
36. [Leiomyomas of the uterine body: Molecular-genetical aspects of formation and development].
Dvorská D; Višňovský J; Braný D; Danko J
Ceska Gynekol; 2016 Jan; 81(1):48-52. PubMed ID: 26982065
[TBL] [Abstract][Full Text] [Related]
37. Comparing regulation of the connexin43 gene by estrogen in uterine leiomyoma and pregnancy myometrium.
Andersen J
Environ Health Perspect; 2000 Oct; 108 Suppl 5():811-5. PubMed ID: 11035987
[TBL] [Abstract][Full Text] [Related]
38. Microstructural changes in uterine leiomyomas and myometrium: a diffusion-weighted magnetic resonance imaging study.
Erdem G; Celik O; Karakas HM; Hascalik S; Firat AK
Gynecol Obstet Invest; 2009; 67(4):217-22. PubMed ID: 19169036
[TBL] [Abstract][Full Text] [Related]
39. Comparative messenger ribonucleic acid analysis of immediate early genes and sex steroid receptors in human leiomyoma and healthy myometrium.
Lessl M; Klotzbuecher M; Schoen S; Reles A; Stöckemann K; Fuhrmann U
J Clin Endocrinol Metab; 1997 Aug; 82(8):2596-600. PubMed ID: 9253340
[TBL] [Abstract][Full Text] [Related]
40. Disease-dependent differently methylated regions (D-DMRs) of DNA are enriched on the X chromosome in uterine leiomyoma.
Maekawa R; Yagi S; Ohgane J; Yamagata Y; Asada H; Tamura I; Sugino N; Shiota K
J Reprod Dev; 2011 Oct; 57(5):604-12. PubMed ID: 21685710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
